| 2013-12-12 | 8-K | 10.9 | Voting Support Agreement, dated as of December 11, 2013, among Emergent BioSolutions Inc., 2396638 Ontario Inc. and Jack Kay. |
|---|
| 2013-12-12 | 8-K | 10.8 | Voting Support Agreement, dated as of December 11, 2013, among Emergent BioSolutions Inc., 2396638 Ontario Inc. and Jeremy B. Desai. |
|---|
| 2013-12-12 | 8-K | 10.7 | Voting Support Agreement, dated as of December 11, 2013, among Emergent BioSolutions Inc., 2396638 Ontario Inc. and R. Craig Baxter. |
|---|
| 2013-12-12 | 8-K | 10.6 | Voting Support Agreement, dated as of December 11, 2013, among Emergent BioSolutions Inc., 2396638 Ontario Inc. and Bernard C. Sherman. |
|---|
| 2013-12-12 | 8-K | 10.5 | Voting Support Agreement, dated as of December 11, 2013, among Emergent BioSolutions Inc., 2396638 Ontario Inc. and Apotex Foundation. |
|---|
| 2013-12-12 | 8-K | 10.4 | Voting Support Agreement, dated as of December 11, 2013, among Emergent BioSolutions Inc., 2396638 Ontario Inc. and Sherman Foundation. |
|---|
| 2013-12-12 | 8-K | 10.3 | Voting Support Agreement, dated as of December 11, 2013, among Emergent BioSolutions Inc., 2396638 Ontario Inc. and Apotex Holdings Inc. |
|---|
| 2013-12-12 | 8-K | 10.2 | Voting Support Agreement, dated as of December 11, 2013, among Emergent BioSolutions Inc., 2396638 Ontario Inc. and Apotex Inc. |
|---|
| 2013-12-12 | 8-K | 10.1 | Credit Agreement, dated as of December 11, 2013, among Emergent BioSolutions Inc., as borrower, certain of its subsidiaries party thereto, as guarantors, Bank of America, N.A., as administrative agent, and certain financial institutions party thereto as lenders. |
|---|
| 2013-11-08 | 10-Q | 10.2 | Modification No. 8 to the CDC BioThrax Procurement Contract, effective September 30, 2013, between Emergent BioDefense Operations Lansing LLC and the Centers for Disease Control and Prevention. |
|---|
| 2013-11-08 | 10-Q | 10.1 | Modification No. 7 to Contract No. 200-2011-42084 (the "CDC BioThrax Procurement Contract"), effective September 26, 2013, between Emergent BioDefense Operations Lansing LLC and the Centers for Disease Control and Prevention. |
|---|
| 2013-08-06 | 10-Q | 10.4 | Modification No. 6 to the CDC BioThrax Procurement Contract, effective June 1, 2013, between Emergent BioDefense Operations Lansing LLC and the Centers for Disease Control and Prevention. |
|---|
| 2013-08-06 | 10-Q | 10.3 | Modification No. 5 to the CDC BioThrax Procurement Contract, effective June 1, 2013, between Emergent BioDefense Operations Lansing LLC and the Centers for Disease Control and Prevention. |
|---|
| 2013-08-06 | 10-Q | 10.2 | Modification No. 4 to the CDC BioThrax Procurement Contract, effective June 1, 2013, between Emergent BioDefense Operations Lansing LLC and the Centers for Disease Control and Prevention. |
|---|
| 2013-08-06 | 10-Q | 10.1 | Modification No. 3 to Contract No. 200-2011-42084 (the "CDC BioThrax Procurement Contract"), effective April 5, 2013, between Emergent BioDefense Operations Lansing LLC and the Centers for Disease Control and Prevention. |
|---|
| 2013-05-03 | 10-Q | 10.2 | Fifth Amendment to the Rockville Lease, dated April 12, 2013, between Brandywine Research LLC and the Company. |
|---|
| 2013-05-03 | 10-Q | 10.1 | Fourth Amendment to Lease Agreement, dated March 27, 2013, between Brandywine Research LLC and the Company (the "Rockville Lease"). |
|---|
| 2013-03-08 | 10-K | 10.8 | exhibit10-8.htm |
|---|
| 2013-03-08 | 10-K | 10.7 | Form of Non-Qualified Stock Option Agreement |
|---|
| 2013-03-08 | 10-K | 10.6 | Form of Director Restricted Stock Unit Agreement |
|---|
| 2013-03-08 | 10-K | 10.5 | Form of Director Nonstatutory Stock Option Agreement |
|---|
| 2013-03-08 | 10-K | 10.1 | Amended and Restated Board Compensation Program |
|---|
| 2013-01-18 | 8-K | 10 | Form of Indemnity Agreement between Emergent BioSolutions Inc. and each of its directors and senior officers. |
|---|